Risperidone in the Treatment of Psychotic-Like and Deficit Symptoms of Schizotypal Personality Disorder

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Mount Sinai School of Medicine.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Janssen Pharmaceutica N.V., Belgium
Information provided by:
Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT00158028
First received: September 8, 2005
Last updated: November 21, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2005
  Estimated Primary Completion Date: No date given